| Literature DB >> 28978471 |
Diogo Gomes-Silva1, Malini Mukherjee2, Madhuwanti Srinivasan3, Giedre Krenciute4, Olga Dakhova3, Yueting Zheng3, Joaquim M S Cabral5, Cliona M Rooney6, Jordan S Orange7, Malcolm K Brenner3, Maksim Mamonkin8.
Abstract
Antigen-independent tonic signaling by chimeric antigen receptors (CARs) can increase differentiation and exhaustion of T cells, limiting their potency. Incorporating 4-1BB costimulation in CARs may enable T cells to resist this functional exhaustion; however, the potential ramifications of tonic 4-1BB signaling in CAR T cells remain unclear. Here, we found that tonic CAR-derived 4-1BB signaling can produce toxicity in T cells via continuous TRAF2-dependent activation of the nuclear factor κB (NF-κB) pathway and augmented FAS-dependent cell death. This mechanism was amplified in a non-self-inactivating gammaretroviral vector through positive feedback on the long terminal repeat (LTR) promoter, further enhancing CAR expression and tonic signaling. Attenuating CAR expression by substitution with a self-inactivating lentiviral vector minimized tonic signaling and improved T cell expansion and anti-tumor function. These studies illuminate the interaction between tonic CAR signaling and the chosen expression platform and identify inhibitory properties of the 4-1BB costimulatory domain that have direct implications for rational CAR design.Entities:
Keywords: 4-1BB; T cells; adoptive T cell therapy; chimeric antigen receptor; costimulation
Mesh:
Substances:
Year: 2017 PMID: 28978471 PMCID: PMC5645034 DOI: 10.1016/j.celrep.2017.09.015
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423